ADMA Biologics ADMA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 61.3%+8.7pp | 57.4%+5.9pp | 54.7%+5.8pp | 53%+6.9pp | 52.6%+13.2pp | |
| Operating margin | 42.1%+9.0pp | 37.5%+4.9pp | 34.2%+4.2pp | 32.8%+7.4pp | 33.1%+17.5pp | |
| Net margin | 32.4%-12.6pp | 28.8%-17.6pp | 42.9%+25.1pp | 44.1%+33.5pp | 45%+46.3pp | |
| Returns | ||||||
| Return on equity | 43.3%-35.2pp | 35.6%-46.1pp | 63.2%+27.6pp | 71.2%+50.5pp | 78.5%+80.9pp | |
| Return on invested capital | 44.8%-25.8pp | 38.6%-27.1pp | 54.9%-26.0pp | 72.6%+10.6pp | 70.7%+33.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×-0.2× | 0.9×-0.1× | 1×0.0× | 1×+0.1× | 1.1×+0.2× | |
| Liquidity | ||||||
| Current ratio | 7×+0.4× | 6.7×+0.7× | 7.1×0.0× | 5.3×-1.5× | 6.6×+1.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×+0.5× | 0.2×-0.1× | 0.2×+0.1× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | 0.3×+0.7× | -0×+0.1× | 0.1×+0.8× | -0.5×+0.5× | -0.4×+0.4× | |
| Per Share | ||||||
| Book value per share | $1.63+6.6% | $1.95+35.9% | $1.76+86.1% | $1.60+106% | $1.53+135% | |
| Valuation | ||||||
| Market capitalization | $2.15B-54.5% | $4.34B+7.1% | $3.5B-24.9% | $4.26B+64.4% | $4.71B+213% | |
| Price / earnings | 13×-9.8× | 29.5×+9.0× | 16.7×-51.7× | 20.4×-54.1× | 22.8×— | |
| Price / sales | 4.2×-6.1× | 8.5×-1.0× | 7.2×-5.0× | 9×+1.1× | 10.3×+4.9× | |
| Price / book | 5.5×-7.1× | 9.1×-2.5× | 8.1×-12.0× | 10.7×-3.1× | 12.6×+2.8× | |
| EV / EBITDA | 9.9×-19.2× | 21.7×-5.8× | 20.1×-20.2× | 25.6×-6.1× | 29.1×-3.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ADMA Biologics's profit margins?
- ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
- Where do ADMA Biologics's ratios come from?
- Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
